Cargando…

The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy

BACKGROUND: In Italy, copayment has changed its nature and it can no longer be simply considered a system to curb inappropriate expenditure. It has become an important form of revenue for public health care provision, but it might also become a source of distortions in income and health benefits red...

Descripción completa

Detalles Bibliográficos
Autores principales: Berta, Paolo, Levaggi, Rosella, Martini, Gianmaria, Verzillo, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423013/
https://www.ncbi.nlm.nih.gov/pubmed/28482834
http://dx.doi.org/10.1186/s12913-017-2248-6
_version_ 1783234883278077952
author Berta, Paolo
Levaggi, Rosella
Martini, Gianmaria
Verzillo, Stefano
author_facet Berta, Paolo
Levaggi, Rosella
Martini, Gianmaria
Verzillo, Stefano
author_sort Berta, Paolo
collection PubMed
description BACKGROUND: In Italy, copayment has changed its nature and it can no longer be simply considered a system to curb inappropriate expenditure. It has become an important form of revenue for public health care provision, but it might also become a source of distortions in income and health benefits redistribution. METHODS: We use a rich administrative dataset gathering information on patients demand (whose records have been matched to income declared for tax purposes) to study the effects of an additional copayment (the so called “superticket” introduced by the Italian government in 2012) in Lombardy, the biggest Italian Region whose socio-economic dimension is comparable to that of many European countries (e.g., the Netherlands, Switzerland, etc.). RESULTS: Our analysis shows that at the aggregate level the non-uniform superticket schedule adopted in Lombardy is slightly pro-poor, but this result coexists with evidences pointing towards possible cases of restriction to access caused by the additional copayment. CONCLUSIONS: The introduction of the superticket and the ensuing increase in the out-of pocket payment for health care raises questions about the distribution of the burden among patients, and the sustainability of the extra revenue through time. This issue needs to be further investigated by combining health status data with the information in this dataset.
format Online
Article
Text
id pubmed-5423013
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-54230132017-05-10 The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy Berta, Paolo Levaggi, Rosella Martini, Gianmaria Verzillo, Stefano BMC Health Serv Res Research Article BACKGROUND: In Italy, copayment has changed its nature and it can no longer be simply considered a system to curb inappropriate expenditure. It has become an important form of revenue for public health care provision, but it might also become a source of distortions in income and health benefits redistribution. METHODS: We use a rich administrative dataset gathering information on patients demand (whose records have been matched to income declared for tax purposes) to study the effects of an additional copayment (the so called “superticket” introduced by the Italian government in 2012) in Lombardy, the biggest Italian Region whose socio-economic dimension is comparable to that of many European countries (e.g., the Netherlands, Switzerland, etc.). RESULTS: Our analysis shows that at the aggregate level the non-uniform superticket schedule adopted in Lombardy is slightly pro-poor, but this result coexists with evidences pointing towards possible cases of restriction to access caused by the additional copayment. CONCLUSIONS: The introduction of the superticket and the ensuing increase in the out-of pocket payment for health care raises questions about the distribution of the burden among patients, and the sustainability of the extra revenue through time. This issue needs to be further investigated by combining health status data with the information in this dataset. BioMed Central 2017-05-08 /pmc/articles/PMC5423013/ /pubmed/28482834 http://dx.doi.org/10.1186/s12913-017-2248-6 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Berta, Paolo
Levaggi, Rosella
Martini, Gianmaria
Verzillo, Stefano
The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy
title The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy
title_full The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy
title_fullStr The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy
title_full_unstemmed The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy
title_short The redistributive effects of copayment in outpatient prescriptions: evidence from Lombardy
title_sort redistributive effects of copayment in outpatient prescriptions: evidence from lombardy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5423013/
https://www.ncbi.nlm.nih.gov/pubmed/28482834
http://dx.doi.org/10.1186/s12913-017-2248-6
work_keys_str_mv AT bertapaolo theredistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy
AT levaggirosella theredistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy
AT martinigianmaria theredistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy
AT verzillostefano theredistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy
AT bertapaolo redistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy
AT levaggirosella redistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy
AT martinigianmaria redistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy
AT verzillostefano redistributiveeffectsofcopaymentinoutpatientprescriptionsevidencefromlombardy